In a report released today, Kian Abouhossein from J.P. Morgan reiterated a Buy rating on Barclays (BARC – Research Report), with a price target of p360.00. The company’s shares opened today at ...

In a report released today, Marcus Diebel from J.P. Morgan maintained a Buy rating on Prosus (PROSF – Research Report), with a price target of

The UK-headquartered bank is proposing to nearly halve the amount of money guaranteed to CEO CS Venkatakrishnan each year while capping his maximum pay package at £14.3m, Sky News can exclusively reveal.

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of Intra-Cellular Therapies to former First Lady Jill Biden’s appearance at Fierce JPM Week.

J.P. Morgan Payments, the payments arm of banking giant JPMorgan Chase & Co., is blazing its own path with two new payment terminals, both proprietary to the payment service.

Whales with a lot of money to spend have taken a noticeably bearish stance on Morgan Stanley. If we consider the specifics of each trade, it is accurate to state that 12% of the investors opened trades with bullish expectations and 62% with bearish.

Ollie's Bargain Outlet Holdings (OLLI) gains after J.P. Morgan adds it to Analyst Focus List, predicts strong growth.

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare Conference, part of what hospitality leaders see as a critical opportunity to showcase safety efforts in the wake of last month's deadly shooting in Manhattan of UnitedHealthcare CEO Brian Thompson.

NextEra Energy (NYSE:NEE – Free Report) had its price target upped by Morgan Stanley from $93.00 to $94.00 in a research report report published on Thursday,Benzinga reports. Morgan Stanley currently has an overweight rating on the utilities provider’s stock.

Morgan Stanley has recently raised American Homes 4 Rent Class A (AMH) stock rating, as announced on January 24, 2025, according to Finviz. Earlier, on January 23, 2025, Scotiabank had reduced the stock from a Sector Outperform to Sector Perform,

Issuance for next week falls to an estimated $5.151 billion, with $3.959 billion of negotiated deals and $1.193 billion of competitive deals on tap.

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The company uses AI and ML for drug discovery, combining computational power with new-age experimental data to offer insights into protein motion and function and identify candidates that can be transformed into novel therapies.